Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6950e2 · Cited by 536

Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Rüggeberg, J. U., Gold, M., Bayas, J. M., Blum, M. D., Bonhoeffer, J., Friedlander, S. F., Brito, G. D. S., Heininger, U., Imoukhuede, E. B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383

Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity — United States, January 26–October 3, 2020

Rossen, L. M., Branum, A. M., Ahmad, F. B., Sutton, P., & Anderson, R. N. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6942e2 · Cited by 373

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Shimabukuro, T. T., & Nair, N. (2021) · JAMA · doi:10.1001/jama.2021.0600 · Cited by 327

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020

Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm695152e1 · Cited by 317

Vaccine-associated hypersensitivity

McNeil, M. M., & Destefano, F. R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.971 · Cited by 274

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021

CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270

The Effect of Self-Compassion Intervention on Academic Motivation and Academic Stress on Mental Health of Students in Hybrid Learning

Shahid, W., & Farhan, S. (2022) · Journal of Professional & Applied Psychology · doi:10.52053/jpap.v3i2.101 · Cited by 3

COVID-19 Vaccines - Current State and Perspectives

Abdurakhmonov, I. Y. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101006 · Cited by 4

Effects of Biological Sex and Pregnancy on SARS-CoV-2 Pathogenesis and Vaccine Outcomes

Shapiro, J. R., Roberts, C. W., Arcovio, K., Reade, L., Klein, S. L., & Dhakal, S. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_4 · Cited by 4

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines

Greenhawt, M., Abrams, E. M., & Shaker, M. S. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab584 · Cited by 3

Innovations and challenges in vaccine development: Lessons from the SARS-CoV-2 pandemic and prospects

Mohammed, A., Ibrahim, N. A., & Basher, N. S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152947 · Cited by 2

Safety of seasonal inactivated influenza vaccines in children 6 months–17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018–2023: before, during, and after the COVID-19 pandemic public health emergency

Anyalechi, G. E., Marquez, P. L., Rubin, M. N., Johannsen, S.-A. P., Kohlman, K., Gunta, J., Works, K. N., Woo, J., Romanson, B., Crist, M. B., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128569 · Cited by 2

Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose

Apostolidou, E., Dimitriou, K., Papadopoulou, A., Mikos, N., & Kompoti, E. (2023) · Cureus · doi:10.7759/cureus.36064 · Cited by 2

The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital

Paoletti, G., Pepys, J., Bragato, M. C., Paoletti, S., Piona, A., Messina, M., Racca, F., Ferri, S., Nappi, E., Costanzo, G., et al. (2023) · Vaccines · doi:10.3390/vaccines11050903 · Cited by 2

Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A decade-long retrospective analysis (2012-2021)

Dagher, J., Antonios, D., Chollet‐Martin, S., de Chaisemartin, L., Pallardy, M. J., Azouri, H., & Irani, C. (2023) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2023.100169 · Cited by 2

Citrobacter freundii-associated osteomyelitis and thromboembolic events following Moderna COVID-19 vaccination: a rare case report from Nepal

Adhikari, S., Sony, K. C., Dev, S., Bhandari, S., Parajuli, P., Poudel, M. B., Adhikari, Y. R., & Poudel, B. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001351 · Cited by 3

Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic

Cracowski, J., Molimard, M., Richard, V. J., Roustit, M., & Khouri, C. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2368811 · Cited by 2

[Illuminating the shadows - perspectives on mRNA vaccine adverse events - mechanisms, risks and management]: A review

Kang, H., Sun, Y., Fang, Z., Ding, W., Bai, T., Yang, K., & Jiang, D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145010 · Cited by 2

Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation

Dézsi, L., Kökény, G., Szénási, G., Révész, C., Mészáros, T., Barta, B. A., Facskó, R., Szilasi, A., Bakos, T., Kozma, G. T., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70563 · Cited by 2

Impact of COVID-19 vaccination on cancer patients: safety, efficacy, and long-term effects

Alshehri, S., Almutawif, Y. A., & Khan, N. U. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09783-1 · Cited by 3

Anaphylaxis and COVID-19 vaccines: Real-time interest using Google Trends

Camacho, B., Aguiar, R., Tanno, L. K., Ansotegui, I. J., & Morais‐Almeida, M. (2021) · World Allergy Organization Journal · doi:10.1016/j.waojou.2021.100570 · Cited by 2

COVID-19 Vaccination in India: Clinical Guidance for Patients with Dermatological Diseases

Chathra, N., & Somaiah, S. (2021) · Clinical Dermatology Review · doi:10.4103/cdr.cdr_48_21 · Cited by 2

Clinical characteristics of COVID-19 patients in Xiaogan, China: comparison between recent imported cases and earlier local cases.

Hu, Y., & Ding, T. (2021) · PubMed Central · Cited by 2

Specialist allergy advice allows vaccination in patients with reactions to COVID‐19 vaccines

Harper, V., Gurugama, P., Ewan, P. W., Nasser, S. M., & Sellaturay, P. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.14069 · Cited by 2

Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19

Fiorelli, D., Caruso, V., Belardi, R., Bernardini, S., & Nuccetelli, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110592 · Cited by 2

Preparing for COVID-19 Vaccination: Guidelines for Healthcare Personnel

Kim, Y. R., Kim, D. J., & Choi, Y. H. (2021) · Korean Journal of Healthcare-Associated Infection Control and Prevention · doi:10.14192/kjicp.2021.26.1.3 · Cited by 2

Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era

Ehianeta, T. S., Mzee, S. A. S., Kehinde, A. M., & Ehianeta, O. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000072 · Cited by 2

Vaccination against COVID-19 for hematologic patients: A review of clinical guidelines

Gavrilina, O. A., & Vasileva, A. N. (2021) · Гематология и трансфузиология · doi:10.35754/0234-5730-2021-66-3-458-470 · Cited by 3

COVID Vaccine and Cardiovascular Risks: A Natural Language Analysis of Vaccine Adverse Event Reports

Zhao, Y., Ison, M. G., & Luo, Y. (2021) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669540 · Cited by 2

Coronavirus Disease-2019 Vaccines and the Vaccination Challenges in India: A Review

Rangraze, I. R., Khan, S. S., & Sayyad, Y. (2021) · Internal Medicine - Open Journal · doi:10.17140/imoj-5-117 · Cited by 2

A Case Report of Prolonged Anaphylaxis after COVID-19 Vaccine

Armstrong, L., & Maguire, N. (2021) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2021.9.53690 · Cited by 2

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over

Alicandro, G., Daccò, V., Cariani, L., Contarini, M., Morlacchi, L. C., Rosazza, C., Sciarrabba, C. S., Ferraro, F., Lanfranchi, C., Orena, B. S., et al. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.02.009 · Cited by 2

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series

Iaboni, A., Jindal, N. L., Betschel, S., & Song, C. (2022) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2022.03.003 · Cited by 2

COVID-19 vaccine hesitancy after side effects to the first vaccine: what are our options?

(2022) · QJM · doi:10.1093/qjmed/hcac106 · Cited by 2

Reacciones adversas y vacunación contra COVID-19 en adultos diabéticos.

Quimis, J. A. I., Quimis, J. J. I., & Macías, C. Z. (2023) · MQRInvestigar · doi:10.56048/mqr20225.7.1.2023.1283-1304 · Cited by 1

National assessment strategy for adults and children with a history of vaccine allergy shows low utility of COVID ‐19 vaccine skin testing

Riggioni, C., Phang, K. F., Tay, S. H., Bever, H. V., Xu, S., Oh, S., Bueno, A., Chua, R., Goh, S. H., Chong, K. W., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13923 · Cited by 2

Safety of COVID-19 vaccination among patients with history of allergic reactions

Furman, K., Kasprzyk-Wieczorkowska, E., Glück, J., & Gawlik, R. (2023) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2023.125767 · Cited by 2

Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions

Messina, M., Crisciotti, C., Pellegrini, L., Nappi, E., Racca, F., Costanzo, G., Moro, L. D., Ferri, S., Puggioni, F., Canonica, G. W., et al. (2023) · Vaccines · doi:10.3390/vaccines11050910 · Cited by 2

Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials

Babu, T. M., Wald, A., & Restar, A. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.06.024 · Cited by 2

Acceptance, Intent, Hesitance, and Attitudes Towards SAR-CoV-2 Vaccines Among Healthcare Workers in Michigan, USA

Effiong, U., Umana, I. P., Haley, H. R., Garcia, J., Cheng, C.-I., Ragina, N. P., & Eruo, F. U. (2023) · Cureus · doi:10.7759/cureus.41225 · Cited by 2

IgA Vasculitis following AstraZeneca/Oxford COVID-19, case report.

Alzoabi, N. M., Alqahtani, J. M., Algamdi, B., Alghamdi, N., Ahmad, A. K., Alkaltham, G. K. I., Beidas, T., & Alakloby, O. M. (2023) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v94i6.12959 · Cited by 2

Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data

Arcolacı, A., Bronte, V., & Zanoni, G. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000769 · Cited by 2

COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction – own observations

(2022) · Przeglad Epidemiologiczny · doi:10.32394/75.28 · Cited by 2

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers

Clair, B. D. S., Hoffman, D. L., McClenathan, B. M., Banks, T. A., & Lee, R. U. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.05.010 · Cited by 2

Determinants of Public Acceptance of the COVID-19 Vaccine: A Systematic Review

Sheykhangafshe, F. B., Farahani, H., & Azadfallah, P. (2022) · International Clinical Neuroscience Journal · doi:10.34172/icnj.2022.19 · Cited by 2

Cough, coronavirus disease 2019, the vaccines, and allergy

Chang, Y. (2021) · Asia Pacific Allergy · doi:10.5415/apallergy.2021.11.e23 · Cited by 2

Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult

Prarthana, T., Bakshi, S., Hanumanthu, V., Nahar, U., & De, D. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17990 · Cited by 1

Royal Jelly-derived Two Compounds, 10-hydroxy-2-decenoic acid and a Biotinylated Royalisin-related Peptide, Alleviate Anaphylactic Hypothermia In vivo

Sato, A., Fukase, T., Yamazaki, M., Watanabe, H., & Ebina, K. (2022) · Journal of Biologically Active Products from Nature · doi:10.1080/22311866.2022.2034530 · Cited by 1

Who decides? Consent for healthcare decisions of minors in the United States

Stettner, N. M., Lavelle, E. N., & Cafferty, P. W. (2023) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001218 · Cited by 1

Can mRNA vaccine against COVID-19 cause pancytopenia?

Hamieh, C., El-Hussein, M., Zahereddine, Y., & Revue, E. (2023) · Intercontinental Journal of Emergency Medicine · doi:10.51271/icjem-0010 · Cited by 1

Vaccination in Patients with Cardiovascular Disease: A Case-Based Approach and Contemporary Review

Sedrak, P., Dounaevskaia, V., Mancini, G. B. J., Zieroth, S. R., McKelvie, R. S., Chiu, W., Bewick, D. J., Ducharme, A., Mansour, S., Lepage, S., et al. (2025) · CJC Open · doi:10.1016/j.cjco.2025.09.004 · Cited by 1

Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women

Maisonneuve, E., Luxi, N., Bellitto, C., Ciccimarra, F., Raethke, M., van Hunsel, F., Lieber, T., Mulder, E., Riefolo, F., Villalobos, F., et al. (2025) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2025.1689349 · Cited by 1

Safety monitoring of health outcomes following RSVPreF3 + AS01 and RSVPreF vaccination among Medicare beneficiaries aged 65 years and older in the United States, 2023–2024

Lloyd, P. C., Shah, P. B., Zhang, H. T., Shah, N., Nair, N., Wan, Z., Hu, M., Clarke, T. C., Chen, M., Chillarige, Y., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128459 · Cited by 1

Factors associated with serious adverse event following immunization: a real-world analysis of the vaccine adverse event reporting system 2025

Pan, X., Chen, Y. P., Chen, F. X., He, H., Qi, X. H., & Liang, H. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1820862 · Cited by 1

mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network

Muller, M. P., Soe, P., Shulha, H. P., Isenor, J. E., Valiquette, L., Sadarangani, M., Vanderkooi, O. G., Kellner, J. D., Top, K. A., Serres, G. D., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128630 · Cited by 2

Beyond PEG: Re-Engineering stealth-polymers to do more than just hide

Kiran, R., Jafari, F. K. A., Strauch, R., & d’Arcy, R. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115944 · Cited by 1

Vaccination COVID en pneumologie.

Blanchard, E. J., Ozier, A., Janssen, C., Wyplosz, B., & Andréjak, C. (2021) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2021.07.003 · Cited by 1

COVID-19 Vaccines

Kamath, V., & Nivea, B. (2021) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_62_21 · Cited by 1

Bayesian learning of Covid-19 vaccine safety while incorporating adverse events ontology

Zhao, B., Zhong, Y., Kang, J., & Zhao, L. (2023) · The Annals of Applied Statistics · doi:10.1214/23-aoas1743 · Cited by 1

Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract

Gáspár, A., Moura, A., Cruz, C., & Borrego, L. M. (2022) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.275 · Cited by 1

Is SARS-CoV-2 Vaccination of Subjects with a Prior History of Allergies Dangerous? Experiences in the Veneto Region of Italy

Cocchio, S., Girolametto, G., Pierobon, A., Furlan, P., Destefani, E., Bulegato, L., Stano, A., Fietta, S., Poletto, A., & Baldo, V. (2023) · Vaccines · doi:10.3390/vaccines11030574 · Cited by 1

Acupuncture as a therapeutic intervention for post-COVID-19 vaccination urticaria: a systematic review and meta-analysis protocol

Wang, Z., Xiao, Y., Wang, M., Chen, Q., Lin, Y., Fang, X., & Wang, W. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073914 · Cited by 1

COVID-19 vaccination hesitancy among patients admitted to the immunology and allergy clinic with drug allergies

Benlioglu, E. H., Durmaz, M. S. B., & Keskin, G. (2023) · Health Sciences Quarterly · doi:10.26900/hsq.2056 · Cited by 1

Vaccination against the SARS-CoV-2 virus in patients undergoing Hymenoptera venom immunotherapy

Żurek, W., Baron, M., Moos, Ł., Kapeluszna, K., Starczewska-Dymek, L., & Brzoza, Z. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2024.139136 · Cited by 1

Correlates of COVID-19 vaccine uptake among the forcibly displaced: evidence from Libya

Achore, M. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01306-4 · Cited by 1

Risk Factors Associated with Cutaneous Reactions Following COVID-19 Vaccine Immunisation: A Registry-Based Case-Control Study

Lin, T. H., Keowmani, T., & Moon, T. M. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.3.10 · Cited by 1

Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI)

Tuyls, S., van der Brempt, X., Faber, M. A., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021) · Acta Clinica Belgica · doi:10.1080/17843286.2021.1909447 · Cited by 1

[MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE].

Asano, K., Fujisawa, T., Nakamura, Y., Nagata, M., Hide, M., & Fujieda, S. (2021) · PubMed · doi:10.15036/arerugi.70.215 · Cited by 1

Adverse events and preventive measures related to COVID-19 vaccines

Ahn, T. K., Kang, S. Y., Paik, J. H., & Seo, Y. H. (2021) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.21.067 · Cited by 1

Vaccines and Vaccination Strategies for Older Adults

Weinberger, B. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_7 · Cited by 1

Safety of covid-19 vaccine prophylaxis: literature review and clinical experience of its implementation

Mamrovskaya, T. (2021) · Dalʹnevostočnyj medicinskij žurnal · doi:10.35177/1994-5191-2021-3-6-12 · Cited by 1

Anafilaxia causada por vacunas

Perea-Valle, P., Delgado-Aguirre, C. J., Villafuerte-Domínguez, B. G., & Del-Rio-Navarro, B. E. (2022) · Revista Alergia México · doi:10.29262/ram.v69isupl1.989 · Cited by 1

新型コロナウイルスに対する治療・予防

Yoshifuji, A., & 竜崎, 崇. (2022) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.55.129 · Cited by 1

Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger

Azem, A., Ajmal, Z., & Raval, M. (2022) · Cureus · doi:10.7759/cureus.25738 · Cited by 1

[Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases in China (2022)].

(2022) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2022.05.002 · Cited by 1

Symptoms and Duration of the Menstrual Cycle and Vaccination against Coronavirus Disease (COVID-19)

AKPERBEKOVA, S. A. (2022) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs07.03.092 · Cited by 1

One year of COVID-19 vaccination

Cheng, M., Zhao, H. J., & Qin, C. (2022) · National Science Open · doi:10.1360/nso/20220007 · Cited by 1

Suspicion d’allergie aux vaccins anti COVID-19 : étude rétrospective sur 320 patients

Gosse, L., Hacard, F., Crumbach, L., Vancappel, M., Bérard, F., Nicolas, J., Vial, T., Juillard, L., Dussard, C., & Nosbaum, A. (2023) · Revue française d'allergologie · doi:10.1016/j.reval.2023.103303 · Cited by 1

Anafylaktiske reaksjoner på vaksine skal meldes som bivirkning

Evensen, G., & Harg, P. (2021) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.21.0154

Praktijkadvies rond de aanpak van anafylaxie bij (Covid-19-)vaccinatie bij kwetsbare ouderen (incl. e-learning)

Duyver, E., VELDE, T. V. D., Razooqi, D., Versluys, K. J. J., PETROVIC, M., & Noortgate, N. V. D. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.033

Farmacovigilance in allergic diseases

Sabin, O., Bocșan, I. C., & Buzoianu, A. D. (2021) · Alergologia · doi:10.26416/aler.5.2.2021.4895

Immunization Update 2021

Wilhelm, M. (2021) · Pharmacy Today · doi:10.1016/j.ptdy.2021.07.022

COVID-19 Vaccination Issues in Solid Organ Transplant Recipients

Parabina, E. V., Konstantinov, D. Y., Kaabak, M. M., Rappoport, N. N., Pushkin, S. Y., Selyutin, A. A., Navasardyan, А. S., Владиславовна, М. У., Alexandrova, V. E., & Yaremin, B. I. (2021) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2021.4.covid.2

O IMPACTO DA PANDEMIA DO CORONAVÍRUS NA SAÚDE MENTAL DOS PROFISSIONAIS DE SAÚDE

Sarmento, A. M. P., Gomes, A. C. Á., Dornelas, D. H. D. S., Teixeira, F. D. C., Oliveira, J. S. D., Canêdo, J. A., Batista, L. M., Marques, L. A. M., Pereira, R. L., SCHACHT, V., et al. (2021) · doi:10.22533/at.ed.5942102096

ATUALIZAÇÕES DA CORTICOTERAPIA NOS PACIENTES EM SUPORTE VENTILATÓRIO PELA COVID-19

Xavier, L. C., Assis, D. S., do Nascimento, I. C. M., Barreto, L. M. L., Borges, L. C. A., Silva, L. E. D. O., Faria, L. P., Souza, M. A. G., Brito, M. S. R., Silva, S. D. C., et al. (2021) · doi:10.22533/at.ed.59421020920

A IMPORTÂNCIA DA ATENÇÃO PRIMÁRIA À SAÚDE NO ENFRENTAMENTO DA PANDEMIA DA COVID-19: UMA ANÁLISE DO MANEJO CLÍNICO NAS UNIDADES BÁSICAS DE SAÚDE

Madeira, F. O. P., Tiburcio, A. G. S., Machado, G. A., Lebourg, J. I., Santos, N. G. O. S., Campos, P. N., Silva, S. L. A. E., Vale, G. F. P., & Neto, R. M. (2021) · doi:10.22533/at.ed.59421020912

Práticas educacionais na pandemia de COVID-19: um relato de experiência

Santos, F. S., Cândido, P. G. G., Santos, R. M. D. M. S., Santos, L. F. S., Neto, M. S., & Costa, A. C. P. D. J. (2021) · Revista Recien · doi:10.24276/rrecien2021.11.35.334-339

Primer of COVID-19 Vaccines for the Perioperative Physician

Lynch, L. R., Clifford, H., Ko, R. R., Haché, M., & Sun, W. (2021) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000802

Thực trạng và kết quả điều trị phản vệ sau tiêm vắc xin Astrazeneca phòng Covid-19 tại Trường Đại học Y Hà Nội

Nguyên, N. M., & Hải, H. B. (2021) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v147i11.634

Vaccination against COVID-19 in Ukraine. Safety of Vaccines

Iakovenko, N. O., Оглобліна, М. В., & Nuzhna, O. K. (2021) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs06.06.200

Zašto neki političari, novinari i zdravstveni djelatnici zagovaraju cijepljenje djece protiv covid-19?Preprint

Gabrić, P. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/sjhra

COVID-19 Vaccines – What are Known? What are not yet known?

Loh, J., & Yew, W. S. (2021) · The Singapore Family Physician · doi:10.33591/sfp.47.7.uo2

Réactions immédiates après l’administration d’un vaccin à ARNm contre le SRAS-CoV-2

Jeimy, S. B., Wong, T. S., & Song, C. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.211581-f

One year of COVID-19 vaccination

Cheng, M., Zhao, H. J., & Qin, C. (2022) · National Science Open · doi:10.1051/nso/2022003

COVID-19 Vaccine Hesitancy in Oncology Patients

Sardina, I. M. V., Kumar, M., & Joseph, R. P. (2021) · Bengal Journal of Cancer · doi:10.4103/bjoc.bjoc_26_21

Clinical Practice and Cases in Emergency Medicine

Nguyen, T. (2022) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2022.2.56356

Why some people tolerate the second dose of a vaccine but not the first dose

Yu, Y. B., Briggs, K. T., & Taraban, M. B. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.01.033

COVID-19 and Historical Parallels

(2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-8689-1.ch007

新型コロナウイルス感染症―治療戦略とワクチンについて―

建部, 将., & 瀬尾, 龍. (2022) · Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) · doi:10.3950/jibiinkotokeibu.125.3_243

Safety profile of COVID-19 vaccines, preventive strategies, and patient management

Prabhu, M. M., Palaian, S., & Ansari, M. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2078311 · Cited by 1

The adverse reactions to vaccines practice parameter 10 years on—what have we learned?

Wolfson, A. R. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.03.028

Anaphylaxie auf Zusatzstoffe in Impfstoffen

Mahler, V., & Junker, A. (2022) · Allergo Journal · doi:10.1007/s15007-022-5054-3

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis

Yoneda, R., Iinuma, T., Sakurai, D., Kurita, J., Arai, T., Sonobe, Y., Yonekura, S., Okamoto, Y., & Hanazawa, T. (2022) · Pathogens · doi:10.3390/pathogens11111280

Reações de hipersensibilidade à vacina contra o vírus Sars-Cov-2

Cavalcanti, M. D. M., Guimarães, L. G., Barros, L. E. D. O., Magalhães, M. F., Cavalcanti, A. D. M., dos Santos, B. A., Coelho, R. L. F. D. S., & Malaman, M. F. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n6-119

Vaccination

Dhami, J., Wang, V. Y., Wang, Z., Brittney, P., Jamie, Y., & Yusin, J. S. (2022) · Springer eBooks · doi:10.1007/978-3-031-12867-7_30

Does switching type of mRNA COVID-19 vaccine increases the risk of myocarditis and pericarditis? A case report and literature review

Aldabbagh, A., & Alaziz, M. (2022) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2022.v4.i2b.409

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Shimabukuro, T. T., & Nair, N. (2021) · JAMA · doi:10.1001/jama.2021.0600 · Cited by 327

Allergic Reactions to the Pfizer-BioNTech and Moderna COVID-19 Vaccines: Early Reports

Baum, S. G. (2021) · Journal watch · doi:10.1056/nejm-jw.na53087 · Cited by 2

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021

CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270

Anaphylaxis to vaccinations: A review of the literature and evaluation of the COVID-19 mRNA vaccinations

Kuder, M. M., Lang, D. M., & Patadia, D. D. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.ccc075 · Cited by 10

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020

CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e1 · Cited by 481